| Chronic condition clusters and polypharmacy among adults A Vyas, X Pan, U Sambamoorthi International journal of family medicine 2012, 2012 | 88 | 2012 |
| Initiation of triple therapy maintenance treatment among patients with COPD in the US JC Simeone, R Luthra, S Kaila, X Pan, TD Bhagnani, J Liu, TK Wilcox International journal of chronic obstructive pulmonary disease, 73-83, 2016 | 76 | 2016 |
| Impact of universal medical insurance system on the accessibility of medical service supply and affordability of patients in China X Xiong, Z Zhang, J Ren, J Zhang, X Pan, L Zhang, S Gong, S Jin PloS one 13 (3), e0193273, 2018 | 67 | 2018 |
| The availability and affordability of orphan drugs for rare diseases in China Shiwei Gong, Yingxiao Wang, Xiaoyun Pan, Liang Zhang, Rui Huang, Xin Chen ... Orphanet Journal of Rare Diseases 11 (20), 2016 | 66 | 2016 |
| Health care expenditures associated with depression in adults with cancer X Pan, U Sambamoorthi The Journal of community and supportive oncology 13 (7), 240, 2015 | 56 | 2015 |
| Patterns and economic burden of hospitalizations and exacerbations among patients diagnosed with idiopathic pulmonary fibrosis YF Yu, N Wu, CC Chuang, R Wang, X Pan, NN Benjamin, G Devercelli, ... Journal of Managed Care & Specialty Pharmacy 22 (4), 414-423, 2016 | 50 | 2016 |
| Immunotherapy treatment patterns and outcomes among ALK-positive patients with non–small-cell lung cancer M Jahanzeb, HM Lin, X Pan, Y Yin, P Baumann, CJ Langer Clinical lung cancer 22 (1), 49-57, 2021 | 48 | 2021 |
| Diffuse large B-cell lymphoma in the elderly: diffusion of treatment with rituximab and survival advances with and without anthracyclines BK Link, J Brooks, K Wright, X Pan, M Voelker, E Chrischilles Leukemia & lymphoma 52 (6), 994-1002, 2011 | 43 | 2011 |
| Osteoporosis risk screening for women in a community pharmacy Y Liu, JC Nevins, KM Carruthers, WR Doucette, RP McDonough, X Pan Journal of the American Pharmacists Association 47 (4), 521-526, 2007 | 27 | 2007 |
| Healthcare resource utilization of second-generation long-acting injectable antipsychotics in schizophrenia: risperidone versus paliperidone palmitate K Joshi, X Pan, R Wang, E Yang, C Benson Current Medical Research and Opinion 32 (11), 1873-1881, 2016 | 25 | 2016 |
| Real‐World Treatment Patterns and Progression‐Free Survival Associated with Anaplastic Lymphoma Kinase (ALK) Tyrosine Kinase Inhibitor Therapies for ALK+ Non‐Small Cell Lung Cancer M Jahanzeb, HM Lin, X Pan, Y Yin, Y Wu, B Nordstrom, MA Socinski The oncologist 25 (10), 867-877, 2020 | 22 | 2020 |
| Depression treatment patterns among individuals with osteoarthritis: a cross sectional study P Agarwal, X Pan, U Sambamoorthi BMC Psychiatry 13 (1), 121, 2013 | 22 | 2013 |
| Healthcare utilization and costs during the initial phase of care among elderly women with breast cancer A Vyas, SS Madhavan, U Sambamoorthi, XL Pan, M Regier, H Hazard, ... Journal of the National Comprehensive Cancer Network 15 (11), 1401-1409, 2017 | 19 | 2017 |
| 中外药品不良反应监测体系的比较分析 潘晓贇， 马爱霞 药学进展 29 (4), 183-186, 2005 | 16 | 2005 |
| Adalimumab real-world dosage pattern and predictors of weekly dosing: patients with Crohn's disease in the United States EV Loftus Jr, X Pan, P Zurawski, P Mulani, J Chao Journal of Crohn's and Colitis 5 (6), 550-554, 2011 | 15 | 2011 |
| Association between Metformin Use and Cancer Stage at Diagnosis among Elderly Medicare Beneficiaries with Pre-existing Type 2 Diabetes Mellitus and Incident Prostate Cancer US Amit Raval, Suresh Madhavan, Malcolm Mattes, Wenhui Wei, Xiaoyun Pan Journal of Diabetes Research, 2016 | 13 | 2016 |
| Economic burden in patients with ALK+ non-small cell lung cancer, with or without brain metastases, receiving second-line anaplastic lymphoma kinase (ALK) inhibitors HM Lin, X Pan, P Hou, H Huang, Y Wu, K Ren, M Jahanzeb Journal of medical economics 23 (8), 894-901, 2020 | 11 | 2020 |
| Prevalence and economic burden of epilepsy in the institutionalized medicare fee-for-service population K Fitch, X Pan, J Lau, T Engel, K Rajagopalan American Health & Drug Benefits 12 (3), 151, 2019 | 10 | 2019 |
| Real-world treatment duration in ALK-positive non-small-cell lung cancer patients receiving brigatinib through the early access program HM Lin, X Pan, P Hou, S Allen, P Baumann, MJ Hochmair Future oncology 16 (15), 1031-1041, 2020 | 8 | 2020 |
| S1040 Dosage Pattern of Adalimumab in Real-World Clinical Practice and Predictors of Dosage Increase in Patients with Crohn's Disease in the US EV Loftus, X Pan, P Zurawski, J Chao, P Mulani Gastroenterology 5 (136), A-175-A-176, 2009 | 8 | 2009 |
Edward V Loftus JrMaxine and Jack Zarrow Family Professor of Gastroenterology, Mayo Clinic College of MedicineE-mail megerősítve itt: mayo.edu
